Investor R&D Day Presentation

79 Macular Edema Secondary to Inflammation How does KSI-101 fit into the emerging treatment landscape? Sumit Sharma MD

Investor R&D Day Presentation - Page 78 Investor R&D Day Presentation Page 77 Page 79